Correlation Between the Serum Level of C-reactive Protein with Short-term Response and Prognosis in Patients with Nonsmall Cell Lung Cancer

XU Chun-hua,YU Li-ke,ZHANG Yu

2012-01-01

Abstract:[Purpose] To investigate the serum level of C-reactive protein (CRP) in non-small cell lung cancer(NSCLC) and its correlation with short-term response and prognosis.[Methods]The concentration of CRP in serum was detected by immunoturbidimetry in 215 cases with NSCLC(105 cases for surgery,and 110 cases for chemotherapy) and 102 healthy controls.The patients were followed for 24 months.[Results] The post-operative patients showed marked reduction in serum CRP comparing with pre-operative patients [(12.52±4.37)mg/L vs (18.13±5.78)mg/L,P0.05].In the 30 patients with tumor remission,CRP post-chemotherapy was significantly lower than that pre-chemotherapy[(10.49±3.85)mg/L vs (18.64±4.63)mg/L,P0.05].In the 44 patients with progressive disease,CRP post-chemotherapy was significantly higher than that pre-chemotherapy [(20.14±7.68)mg/L vs (14.53±4.56)mg/L,P0.05].The CRP concentration did not differ significantly before and after chemotherapy in 36 patients with stable disease.The positive rates of CRP decreased significantly post-operation,but there was no significant change after chemotherapy.During the follow-up for operation patients,the rate of relapse and metastasis(26.7%) was higher in patients with a preoperative positive CRP than those with a negative CRP(7.5%).[Conclusions]Serum CRP might be a useful marker in the prediction of tumor metastases in NSCLC and is helpful for evaluating treatment response and prognosis.